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Blood and lymphatic vessel proliferation is essential for tumor growth and progression. Most colorectal carcinomas develop from
adenomas (adenoma-carcinoma sequence) in a process due to accumulation of molecular genetic alterations. About 5% of
adenomatous polyps are expected to become malignant, but data on the differential angiogenic patterns of these lesions in
patients with and without concomitant cancer are missing. The aim of the present study is to compare the angiogenic and
lymphatic patterns of adenomatous polyps from patients with and without sporadic cancer. Thirty adenomatous polyps (15 from
patients with another principal malignant lesion, and 15 from patients without cancer) were submitted to immunohistochemical
staining for CD105 (marker for neoangiogenesis) and D2-40 (marker for lymphatic endothelium). Microvessel density and total
vascular area were determined by computer image analysis to quantify the immunostained and total areas, and to assess the
number of microvessels. Adenomas from patients with carcinoma showed significantly higher values of total vascular area
determined by immunostaining for CD105 (cutoff value = 4386 μm2; P = 0.019) and of lymphatic microvessel density determined
by immunostaining with D2-40 (cutoff value = 11.5; P = 0.041) when compared with those from patients without cancer. The
present data indicate a significant increase in blood microvascular area and in lymphatic microvascular counts in adenomas
removed from patients with cancer.
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Introduction
Colorectal carcinoma (CRC) represents an important
cause of cancer mortality in industrialized countries. Most
cases (80%) correspond to sporadic carcinomas and arise
from colorectal adenomas (1). The adenoma-carcinoma
sequence involves accumulations of genetic alterations caus-
ing progressive disorders in the cell cycle (2). About 5%
adenomatous polyps will probably become malignant (3).
Angiogenesis plays an important role in tumor progres-
sion and metastasis in most human solid tumors (4-7). This
fact has led to new perspectives in the research of prog-
nostic indicators and of new therapeutic strategies. The
fact that 20-30% of patients with CRC treated with poten-
tially curative surgery succumb from recurrent disease
suggests that the conventional prognostic factors are not
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totally sufficient (8-11).
Most studies have evaluated angiogenesis as a poten-
tial prognostic or predictive factor in CRC both in early and
advanced disease (12,13). Comparison of literature data
has been frequently hindered by variations in patient man-
agement, such as indication of adjuvant therapy, and in the
methods for analysis of angiogenesis (different immuno-
histochemical markers, quantification methods, param-
eters quantified, etc.) (12,14,15).
Endoglin (CD105) is a membrane glycoprotein, part of
the TGF-beta receptor complex, involved in angiogenesis.
Markers for this protein identify newly formed blood ves-
sels, representing a helpful tool in the evaluation of neoan-
giogenesis (16). In CRC, CD105 has been correlated to
prediction of metastasis (17).
D2-40 is a monoclonal antibody directed against the
oncofetal antigen M2A, present in germ cells, lymphatic
endothelium, and some neoplasms such as mesothelio-
mas (18,19). Using this antibody, it has been demon-
strated that the colorectal mucosa indeed presents lym-
phatic vessels in normal, inflammatory and neoplastic
conditions (20,21). However, in contrast to CD105, pres-
ent in newly formed blood vessels, the presence of D2-40
does not indicate the degree of neolymphangiogenesis.
Lymphatic vessel density assessed by D2-40 has been
correlated with the prediction of metastasis and with a poor
outcome of CRC (22-24).
In spite of the many reports on angiogenesis in cancer,
data on the differential angiogenic patterns of adenomatous
lesions in patients with and without concomitant CRC are
not available. The purpose of the present study was to
compare blood angiogenesis and lymphatic vessels be-
tween two groups of adenomatous polyps, one from pa-
tients with concomitant CRC at another site of the mucosa,
and the other from patients without carcinoma, using mi-
crovessel counting and total vascular area determination
with image analysis software. Our aim was to determine
potential differences between adenomatous polyps from
the two groups of patients, and weather the presence of




A retrospective study was performed on 30 low-grade
adenomatous polyps removed by endoscopy or surgery
from 15 patients with sporadic CRC and 15 patients with-
out carcinoma. The latter group did not show evidence of
carcinoma from the time of the procedure throughout a 5-
year follow-up. Hamartomatous and inflammatory polyps
were excluded from the study.
The samples were selected from the files of the Depart-
ment of Pathology, State University of Campinas Hospital,
Campinas, SP, Brazil, and included patients diagnosed
from 1987 to 2003. The group of patients with CRC con-
sisted of 8 males and 7 females ranging from 33 to 82
years (median: 61 years); 5 cases were staged as I, 7 as II,
2 as III, and 1 as IV, according to the TNM pathological
staging system (25). Only low-grade adenomatous polyps,
which had been removed from the colorectal mucosa
concomitantly to or soon after the diagnosis of the main
malignant lesion, without the effect of neoadjuvant thera-
py, were included. There were 8 tubular, 6 tubulovillous,
and 1 villous adenomas.
In the group of patients without a diagnosis of CRC 9
were males and 6 were females ranging from 20 to 82
years (median: 56 years). There were 11 tubular and 4
tubulovillous adenomas.
Immunohistochemistry
Tissue specimens had been fixed in 10% formalin and
embedded in paraffin and 3-μm thick sections were placed
on silanized slides. Endogenous peroxidase activity was
quenched by incubating the slides with 3% H2O2 for 10
min. Antigen retrieval was achieved by microwaving tissue
sections in 10 mM citrate buffer, pH 6.0, in four cycles of 5
min each. Sections were incubated at room temperature
for 20 min with mouse monoclonal antibodies to CD105
(Endoglin, Clone SN6h, Dako, USA; diluted 1:15) and to
D2-40 (Dako, diluted 1:400). Antigen-antibody binding was
detected using the Advance system (Dako). Internal and
external positive and negative controls were run concomi-
tantly in each reaction batch.
Evaluation of immunohistochemistry
Digital images from two “hot spot” fields stained by
each marker were captured. One area corresponded to the
upper/inner portions of the lesions, and the other to the
deeper area of the polyps. The upper/inner areas were
grouped together because there were some small ad-
enomas in which both areas appeared in the same image.
Digitalization was done at 200X magnification, 120 dpi,
using a digital camera (Leica DFC360 FX, Leica, Ger-
many) connected to a bright field microscope (Leica
DM5000 B).
The images were examined with image analysis soft-
ware (Leica QWin Standard V3, Microsystem Imaging,
Leica) set to detect color intensities in a fixed and constant
range. Every image was evaluated using this standardized
program to quantify the proportion between stained and
total areas and to assess the number of microvessels.
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Immunostained blood and lymphatic vessels were marked
with a circle by the pathologist who analyzed the image to
perform automated quantification. An example of the re-
sulting image prepared for analysis after selection of the
immunostained vessels is shown in Figure 1. This resulted
in the evaluation of two parameters for each marker: micro-
vessel density (MVD) and total vascular area (TVA).
Statistical analysis
Statistical analysis was performed using the SAS Sys-
tem for Windows software package (version 9.1.3). For the
quantitative parameters, the minimum and maximum val-
ues, mean, standard deviation, and median were ana-
lyzed. For the qualitative variables, the absolute and rela-
tive frequencies were analyzed. The non-parametric Mann-
Whitney test was used to compare two groups and the
Kruskal-Wallis test was used for three or more groups. The
Dunn comparison test was used for multiple comparisons.
The level of significance was set at 5% in all analyses.
Results
CD105 in adenomas from patients with CRC
MVD ranged from 0 to 15 (median 5; mean 5.53) in “hot
spots” of the upper/inner parts of adenomas and from 0 to
37 (median 1; mean 5.40) in the deeper areas. TVA ranged
from 0 to 219905 μm2 (median 7498; mean 25681.33 μm2)
in the “hot spots” of the upper/inner regions and from 0 to
27255 μm2 (median 755; mean 6215.00 μm2) in the deeper
area.
CD105 in adenomas from patients without CRC
MVD ranged from 0 to 10 (median 2; mean 3.20) in “hot
spots” of the upper/inner part of adenomas and from 0 to
10 (median 1; mean 2.53) in the deeper area. TVA ranged
from 0 to 19660 μm2 (median 183; mean 3810.20 μm2), in
the “hot spots” of the upper/inner parts and from 0 to 66522
μm2 (median 143; mean 8114.40 μm2) in the deeper area
The results for CD105 are summarized in Table 1.
Figure 1. Evaluation of microvessels in immunostained sections by computer image analysis: the positive vessels are delimited in red
and their area was calculated by software. 
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D2-40 in adenomas in patients
with CRC
MVD ranged from 4 to 177 (me-
dian 12; mean 29.20) in “hot spots”
of the upper/inner parts of the ad-
enoma and TVA ranged from 85 to
40691 μm2 (median 3914; mean
9232.00 μm2). MVD ranged from 1
to 37 (median 12; mean 14.67) in
“hot spots” of the deeper area, and
TVA ranged from 676 to 64650 μm2
(median 9563; mean 18473.73 μm2).
D2-40 in adenomas from patients
without CRC
MVD ranged from 1 to 18 (me-
dian 8; mean 8.40) in “hot spots” of
the upper/inner parts of the adenoma
and TVA ranged from 1 to 53112
μm2 (median 5836; mean 11592.47
μm2). MVD ranged from 2 to 14 (me-
dian 8; mean 8.27) in “hot spots” of
the deeper area and TVA ranged
from 265 to 44491 μm2 (median
8687; mean 14430.73 μm2). The re-
sults for D2-40 are summarized in
Table 2. A plate with illustrations of
cases with lower and higher vascu-
larization using both markers is
shown in Figure 2. 
Table 1. Microvessel density (MVD; number of microvessels counted) and total vascular
area (TVA, μm2) determined by immunostaining for CD105 in the two areas (upper/inner
and deeper) of adenomas in 15 patients with CRC and 15 patients with no CRC.
Variables Area Patient group Range Mean ± SD Median
MVD Upper/inner CRC 0-15 5.53 ± 5.22 5
No CRC 0-10 3.20 ± 3.41 2
Deeper CRC 0-37 5.40 ± 9.56 1
No CRC 0-10 2.53 ± 3.27 1
TVA Upper/inner CRC 0-219905 25681.33 ± 55338.71* 7498
No CRC 0-19660 3810.20 ± 5910.57 183
Deeper CRC 0-27255 6215.00 ± 9110.95 755
No CRC 0-66522 8114.40 ± 17675.36 143
CRC = colorectal cancer; No CRC = no colorectal cancer; SD = standard deviation. *P <
0.05 compared to No CRC (non-parametric Mann-Whitney test).
Figure 2. Various degrees of vascular-
ization using anti-CD105 and D2-40: low
and high values are shown (original
magnification, 200X). A, CD105, High
vascularization (arrows); B, CD105, low
vascularization; C, D2-40, high vascu-
larization (arrows); D, D2-40, low vascu-
larization.
Table 2. Lymphatic microvessel density (MVD; number of lymphatic microvessels counted)
and total vascular area (TVA, μm2) determined by immunostaining for D2-40 in the two
areas (upper/inner and deeper) of adenomas in 15 patients with CRC and 15 patients with
no CRC.
Variables Area Patient group Range Mean ± SD Median
MVD Upper/inner CRC 4-177 29.20 ± 44.74* 12
No CRC 1-18 8.40 ± 5.58 8
Deeper CRC 1-37 14.67 ± 10.31 12
No CRC 2-14 8.27 ± 3.28 8
TVA Upper/inner CRC 85-40691 9232.00 ± 11023.34 3914
No CRC 1-53112 11592.47 ± 15384.84 5836
Deeper CRC 676-64650 18473.73 ± 20906.02 9563
No CRC 265-44491 14430.73 ± 14044.96 8687
CRC = colorectal cancer; No CRC = no colorectal cancer; SD = standard deviation. *P <
0.05 compared to No CRC (non-parametric Mann-Whitney test).
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Statistical analysis of these data showed significantly
higher values of TVA determined by immunostaining for
CD105 (P = 0.019) and of MVD determined by immuno-
staining for D2-40 (P = 0.041) when compared with those
from patients without CRC.
For both markers, there was no significant difference
among histological types of adenoma (tubular, tubulovillous
and villous) and MVD or TVA counts, in the groups of
patients with and without CRC.
The cutoff value for TVA determined by CD105 in the
upper/inner parts of the adenomas was 4386, or approxi-
mately 4400 μm2 (sensitivity and specificity: 66.7%; pre-
dictive positive and predictive negative values: 66.7%;
accuracy: 66.7%). The cutoff value of MVD determined by
D2-40 in the upper/inner parts of the adenomas was 11.5
(60.0% sensitivity, 66.7% specificity, 64.3% predictive posi-
tive value, 62.5% predictive negative value, and 63.3%
accuracy).
Discussion
The present data indicate a significant increase in
blood microvascular area and in lymphatic microvascular
counts in the upper and inner portions of adenomas re-
moved from patients with CRC compared to those without
carcinoma. Cancer cells might have an influence on the
vascularization of adenomas, evidence supported by data
showing increased levels of angiogenic factors in colorec-
tal tissues distant from the primary tumor. Hanrahan et al.
(26) showed that vascular endothelial growth factor (VEGF)
plays a role early in tumor development at the stage of
adenoma formation. Moreover, increased levels of VEGF
in normal tissue collected from sites distant from the pri-
mary tumor have indicated environmental changes that
could help explain our findings, although this was not
directly assessed in our material.
The more significant increase in lymphatic MVD in the
upper/inner areas of the adenomas is in keeping with a
previous study reporting a more superficial location of
lymphatic vessels in adenomas. This finding supports the
hypothesis sustained by Fogt et al. (20) that superficial
lymphatic vessels may be immature in normal colonic
mucosa and may not communicate with deeper vessels,
changing and maturing through the adenoma-carcinoma
process. An equivalent assumption could be made about
the increase in newly formed blood vessels detected by
CD105, which suggests that they may originate superfi-
cially on adenomas, developing and meeting deeper ves-
sels during the progression of malignancy.
The assessment of TVA using immunostaining for
CD105 showed significantly higher values in adenomas
from patients with CRC, while assessment of MVD did not.
The opposite was seen in the assessment of lymphatic
vessels using the D2-40 antibody: in contrast to MVD, TVA
did not differ significantly between the two groups of le-
sions. These differences might reflect variations in the
mechanisms of proliferation of blood and lymphatic ves-
sels, the former affecting predominantly architectural
scores, and the latter numerical scores. Unlike normal
blood vessels, newly formed blood vessels incorporated
during tumor angiogenesis are tortuous and dilated, a fact
that could explain the higher value of TVA using CD105 in
patients with CRC, an aspect supported by experimental
studies (27). The higher MVD evaluated by D2-40 in pa-
tients with CRC could be explained by recent evidence
showing elevated lymphatic vessel counts as an event
preceding the increased number of blood vessels in early
gastrointestinal tumors (28). It should be noted that com-
puter image analysis seems to be more objective and
reproducible, reducing to minimum intraobserver variabil-
ity from case to case, and increasing the reliability of
information in the study of angiogenesis (29).
The findings reported in the present study support the
notion that neoangiogenesis and elevated lymphatic ves-
sel counts occur in colorectal adenomas from patients with
CRC, allowing us to assume that either angiogenic factors
produced by the carcinoma or constitutional defects of the
colorectal epithelial cells might account for these observa-
tions.
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